BioCentury
ARTICLE | Company News

Avestha, Manipal AcuNova Ltd. deal

May 14, 2007 7:00 AM UTC

The companies partnered to develop diagnostics and perform contract research. For diagnostics, Avestha will use its SNP analysis technology to develop molecular diagnostics for all indications and use systems biology to identify novel biomarkers for predictive diagnostics in metabolic and degenerative diseases. Manipal will be responsible for clinically validating resulting diagnostic products. The companies will jointly own resulting IP. ...